These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 20184585

  • 1. p75 Neurotrophin receptor differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma: insights into the histogenesis of adnexal tumours based on embryology and hair follicle biology.
    Krahl D, Sellheyer K.
    Br J Dermatol; 2010 Jul; 163(1):138-45. PubMed ID: 20184585
    [Abstract] [Full Text] [Related]

  • 2. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.
    Sellheyer K, Krahl D.
    Br J Dermatol; 2011 Jan; 164(1):141-7. PubMed ID: 20846311
    [Abstract] [Full Text] [Related]

  • 3. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
    Jedrych J, McNiff JM.
    Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
    [Abstract] [Full Text] [Related]

  • 4. Basal cell carcinoma and pilomatrixoma mirror human follicular embryogenesis as reflected by their differential expression patterns of SOX9 and β-catenin.
    Krahl D, Sellheyer K.
    Br J Dermatol; 2010 Jun; 162(6):1294-301. PubMed ID: 20105172
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of androgen receptor by fibroepithelioma of Pinkus: evidence supporting classification as a basal cell carcinoma variant?
    Katona TM, Ravis SM, Perkins SM, Moores WB, Billings SD.
    Am J Dermatopathol; 2007 Feb; 29(1):7-12. PubMed ID: 17284955
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fibroepithelioma of Pinkus is a true basal cell carcinoma developing in association with a newly identified tumour-specific type of epidermal hyperplasia.
    Sellheyer K, Nelson P, Kutzner H.
    Br J Dermatol; 2012 Jan; 166(1):88-97. PubMed ID: 21910710
    [Abstract] [Full Text] [Related]

  • 9. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
    Fan YS, Carr RA, Sanders DS, Smith AP, Lazar AJ, Calonje E.
    Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
    [Abstract] [Full Text] [Related]

  • 10. CD10 for the distinct differential diagnosis of basal cell carcinoma and benign tumours of cutaneous appendages originating from hair follicle.
    Sengul D, Sengul I, Astarci MH, Ustun H, Mocan G.
    Pol J Pathol; 2010 Jul; 61(3):140-6. PubMed ID: 21225496
    [Abstract] [Full Text] [Related]

  • 11. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
    Sellheyer K, Nelson P, Kutzner H, Patel RM.
    J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
    [Abstract] [Full Text] [Related]

  • 12. SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms.
    Vidal VP, Ortonne N, Schedl A.
    J Cutan Pathol; 2008 Apr; 35(4):373-9. PubMed ID: 18333897
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
    Krahl D, Sellheyer K.
    J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
    [Abstract] [Full Text] [Related]

  • 14. Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis.
    Tran TA, Muller S, Chaudahri PJ, Carlson JA.
    J Cutan Pathol; 2005 Jan; 32(1):2-11. PubMed ID: 15660649
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma].
    Mitcov M, Scrivener Y, Cribier B.
    Ann Dermatol Venereol; 2009 Jan; 136(6-7):501-7. PubMed ID: 19560610
    [Abstract] [Full Text] [Related]

  • 17. For Valentine's Day: adnexal induction over dermatofibroma.
    Kacerovska D, Michal M, Kazakov DV.
    Int J Surg Pathol; 2009 Dec; 17(6):452-3. PubMed ID: 19828594
    [No Abstract] [Full Text] [Related]

  • 18. High-grade trichoblastic carcinosarcoma.
    Kazakov DV, Vittay G, Michal M, Calonje E.
    Am J Dermatopathol; 2008 Feb; 30(1):62-4. PubMed ID: 18212548
    [Abstract] [Full Text] [Related]

  • 19. Skin-type adnexal tumor with trichoblastic germinative differentiation in the breast: a case report.
    Gököz O, Presenti L, Gambacorta G, Zolfanelli F, Tricarico R, Nistri R, Baroni G, Bianchi S, Massi D.
    Int J Surg Pathol; 2011 Aug; 19(4):527-33. PubMed ID: 19468034
    [Abstract] [Full Text] [Related]

  • 20. Ln-γ 2 chain of laminin-332 is a useful marker in differentiating between benign and malignant sclerosing adnexal neoplasms.
    Koga K, Anan T, Fukumoto T, Fujimoto M, Nabeshima K.
    Histopathology; 2020 Jan; 76(2):318-324. PubMed ID: 31429981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.